Материал: part03

Скачать

Заказать новую работу

Внимание! Если размещение файла нарушает Ваши авторские права, то обязательно сообщите нам

 

DICOM PS3.3 2020a - Information Object Definitions​

Page 491​

Attribute Name​

Tag​

Type​

Attribute Description​

 

Measured AP Dimension​

(0010,1023)​

3​

The thickness in mm of the body part being scanned, in the​

 

 

 

antero-posterior dimension (per AAPM Report 204).​

 

 

 

Note​

 

 

 

 

These values are normally derived from a scanned​

 

 

 

image, but might also be obtained using physical​

 

 

 

calipers, e.g., for children.​

 

Measured Lateral Dimension​

(0010,1024)​

3​

The side-to-side (left to right) dimension in mm of the body​

 

 

 

part being scanned (per AAPM Report 204).​

 

 

 

 

Note​

 

 

 

 

These values are normally derived from a scanned​

 

 

 

image, but might also be obtained using physical​

 

 

 

calipers, e.g., for children.​

 

Patient'sSizeCodeSequence​

(0010,1021)​

3​

Patient's size category code​

 

 

 

 

One or more Items are permitted in this Sequence.​

>Include Table 8.8-1 “Code Sequence Macro Attributes”​

 

Baseline CID is CID 7039 “Pediatric Size Categories” for​

 

 

 

pediatric patients​

 

 

 

 

Baseline CID is CID 7041 “Calcium Scoring Patient Size​

 

 

 

Categories” for CT calcium scoring​

 

Medical Alerts​

(0010,2000)​

3​

Conditions to which medical staff should be alerted (e.g.,​

 

 

 

contagious condition, drug allergies, etc.)​

 

Allergies​

(0010,2110)​

3​

Descriptionofpriorreactiontocontrastagents,orotherpatient​

 

 

 

allergies or adverse reactions.​

 

Smoking Status​

(0010,21A0)​

3​

Indicates whether Patient smokes.​

 

 

 

 

Enumerated Values:​

 

 

 

 

YES​

 

 

 

 

NO​

 

 

 

 

UNKNOWN​

 

Pregnancy Status​

(0010,21C0)​

3​

Describes pregnancy state of Patient.​

 

 

 

 

Enumerated Values:​

 

 

 

 

0001​not pregnant​

 

 

 

 

0002​possibly pregnant​

 

 

 

 

0003​definitely pregnant​

 

 

 

 

0004​unknown​

 

Last Menstrual Date​

(0010,21D0)​

3​

Date of onset of last menstrual period​

 

Patient State​

(0038,0500)​

3​

Description of Patient state (comatose, disoriented, vision​

 

 

 

impaired, etc.)​

 

Occupation​

(0010,2180)​

3​

Occupation of the Patient.​

 

Additional Patient History​

(0010,21B0)​

3​

Additional information about the Patient's medical history.​

- Standard -​

Page 492​

DICOM PS3.3 2020a - Information Object Definitions​

Attribute Name​

Tag​

Type​

Attribute Description​

Admission ID​

(0038,0010)​

3​

Identifier of the Visit as assigned by the healthcare provider​

 

 

 

Note​

 

 

 

Visit and Admission are used interchangeably here.​

 

 

 

In the broader sense, an admission is a type of visit​

 

 

 

at an institution where there is an admission process​

 

 

 

for patients.​

Issuer of Admission ID​

(0038,0014)​

3​

Identifier of the Assigning Authority that issued Admission ID​

Sequence​

 

 

(0038,0010).​

 

 

 

Only a single Item is permitted in this Sequence.​

>Include Table 10-17 “HL7v2 Hierarchic Designator Macro Attributes”​

Reason for Visit​

(0032,1066)​

3​

Reason(s) for this visit by the patient to the facility or provider.​

Reason for Visit Code​

(0032,1067)​

3​

Coded reason(s) for this visit by the patient to the facility or​

Sequence​

 

 

provider.​

 

 

 

Note​

 

 

 

If an HL7 message is available with a PV2 segment​

 

 

 

corresponding to this visit, potential codes may be​

 

 

 

found in Admit Reason PV2-3.​

 

 

 

One or more Items are permitted in this Sequence.​

>Include Table 8.8-1 “Code Sequence Macro Attributes”​

 

No Baseline CID is defined.​

Service Episode ID​

(0038,0060)​

3​

IdentifieroftheServiceEpisodeasassignedbythehealthcare​

 

 

 

provider​

Issuer of Service Episode ID​

(0038,0064)​

3​

Identifier of the Assigning Authority that issued the Service​

Sequence​

 

 

Episode ID (0038,0060).​

 

 

 

Only a single Item is permitted in this Sequence.​

>Include Table 10-17 “HL7v2 Hierarchic Designator Macro Attributes”​

Service Episode Description​

(0038,0062)​

3​

Description of the type of service episode.​

Patient's Sex Neutered​

(0010,2203)​

2C​

Whether or not a procedure has been performed in an effort​

 

 

 

to render the Patient sterile.​

Enumerated Values:​

ALTERED​ Altered/Neutered​

UNALTERED​Unaltered/intact​

Note​

If this Attribute is present but has no value then the​ status is unknown.​

Required if Patient is an animal. May be present otherwise.​

C.7.2.3 Clinical Trial Study Module​

Table C.7-4b contains Attributes that identify a Study in the context of a clinical trial or research.​

- Standard -​

DICOM PS3.3 2020a - Information Object Definitions​ Page 493​

Table C.7-4b. Clinical Trial Study Module Attributes​

Attribute Name​

Tag​

Type​

Attribute Description​

Clinical Trial Time Point ID​ (0012,0050)​

2​

An identifier specifying the one or more Studies that are grouped together as​

 

 

 

a clinical time point or submission in a clinical trial or research. See​

 

 

 

Section C.7.2.3.1.1.​

Clinical Trial Time Point​

(0012,0051)​

3​

A description of a set of one or more Studies that are grouped together to​

Description​

 

 

represent a clinical time point or submission in a clinical trial or research. See​

 

 

 

Section C.7.2.3.1.1.​

Longitudinal Temporal​

(0012,0052)​

3​

An offset in days from a particular event of significance. May be fractional. In​

Offset from Event​

 

 

the context of a clinical trial, this is often the days since enrollment, or the​

 

 

 

baseline imaging Study.​

Longitudinal Temporal​

(0012,0053)​

1C​

The type of event to which Longitudinal Temporal Offset from Event​

Event Type​

 

 

(0012,0052) is relative.​

 

 

 

Defined Terms:​

 

 

 

ENROLLMENT​Relative to enrollment of the subject in the research activity​

 

 

 

or clinical trial.​

 

 

 

BASELINE​ Relative to the baseline imaging Study.​

 

 

 

Required if Longitudinal Temporal Offset from Event (0012,0052) is present.​

Consent for Clinical Trial​

(0012,0083)​

3​

A Sequence that conveys information about consent for Clinical Trial or​

Use Sequence​

 

 

research use of the Composite Instances within this Study.​

 

 

 

One or more Items are permitted in this Sequence.​

 

 

 

See Section C.7.2.3.1.2.​

>Distribution Type​

(0012,0084)​

1C​

The type of distribution for which consent to distribute has been granted.​

 

 

 

Defined Terms:​

 

 

 

NAMED_PROTOCOL​

 

 

 

RESTRICTED_REUSE​

 

 

 

PUBLIC_RELEASE​

 

 

 

See Section C.7.2.3.1.2.​

 

 

 

Required if Consent for Distribution Flag (0012,0085) equals YES or​

 

 

 

WITHDRAWN.​

>Clinical Trial Protocol ID​

(0012,0020)​

1C​

Theidentifieroftheprotocolforwhichconsenttodistributehasbeengranted.​

 

 

 

Required if Distribution Type (0012,0084) is NAMED_PROTOCOL and the​

 

 

 

protocol is not that which is specified in Clinical Trial Protocol ID (0012,0020)​

 

 

 

in the Clinical Trial Subject Module.​

- Standard -​

Page 494​

DICOM PS3.3 2020a - Information Object Definitions​

Attribute Name​

Tag​

Type​

Attribute Description​

>Consent for Distribution​

(0012,0085)​

1​

Whether or not consent to distribute has been granted for the purpose​

Flag​

 

 

described in Distribution Type (0012,0084).​

Enumerated Values:​

NO​

YES​

WITHDRAWN​

See Section C.7.2.3.1.2.​

Note​

Undersomecircumstances,consentmaybewithdrawn.Thepurpose​ ofencodingthisistowarnreceivingsystemsthatfurtherdistribution​ may not be appropriate, but no semantics are defined by the​ Standard for what action is appropriate under such circumstances,​ suchaswhattodowithpreviouslyreceivedimagesthathadavalue​ of YES.​

C.7.2.3.1 Clinical Trial Study Attribute Descriptions​

C.7.2.3.1.1 Clinical Trial Time Point​

The Clinical Trial Time Point ID (0012,0050) Attribute identifies an imaging Study within the context of an investigational protocol.​ This Attribute is used to define a set of Studies that are grouped together as a clinical time point or data submission in a clinical trial​ or research. The Clinical Trial Time Point Description (0012,0051) Attribute can be used to give a description of the Clinical Trial Time​ Point to which the set of Studies belongs.​

C.7.2.3.1.2 Consent For Clinical Trial Use Sequence​

For applications such as clinical trials or research, the distribution of Composite Instances in Studies, whether containing identifying​ information or partially or completely de-identified, may need to be controlled. Permission for distribution is usually granted under the​ control of the Patient (through informed consent), the ethics committee or institutional review board responsible for the Study, and​ the sponsor of the Study through contractual means. The Consent for Clinical Trial Use Sequence (0012,0083) is intended to encode​ the result of the consent process to allow appropriate subsequent handling of the instances.​

The Defined Terms for Distribution Type (0012,0084) mean that consent has been issued to distribute for the following purposes:​

Defined Terms:​

NAMED_PROTOCOL​conducting the protocol named in Clinical Trial Protocol ID (0012,0020)​

RESTRICTED_REUSE​re-use for restricted purposes (not specified here) other than those for which the instances were originally​ created​

PUBLIC_RELEASE​ release to the general public for re-use without restriction​

Note​

1.​There is no intent to convey in this Sequence further details of the often complex consent and approval process. Further​ information about the protocol and ethics committee may be found in the Clinical Trials Modules, if present.​

2.​There is no identification of an individual responsible for the approval or granting consent, since in the case of a clinical​ trial or research subject granting informed consent, the presence of this information would breach de-identification re-​ quirements.​

3.​Multiple Sequence Items may be present; for example a Study may be approved for distribution for conducting multiple​ explicitly named protocols.​

4.​Whether or not the instances have been adequately de-identified for any particular purpose of distribution is not defined​ by the Attributes in the Consent for Clinical Trial Use Sequence (0012,0083). Other Attributes address this, such as​

- Standard -​

DICOM PS3.3 2020a - Information Object Definitions​

Page 495​

PatientIdentityRemoved(0012,0062),De-identificationMethod(0012,0063),De-identificationMethodCodeSequence​ (0012,0064) and Burned In Annotation (0028,0301). See also Annex E “Attribute Confidentiality Profiles” in PS3.15.​

5.​ItispossiblethatthelistofDefinedTermsforDistributionType(0012,0084)maybeextendedinfutureforotherpurposes,​ not necessarily related to the conduct of clinical trials or research.​

C.7.3 Common Series IE Modules​

The following Series IE Modules are common to all Composite Image IODs that reference the Series IE.​

C.7.3.1 General Series Module​

Table C.7-5a specifies the Attributes that identify and describe general information about the Series within a Study.​

Table C.7-5a. General Series Module Attributes​

Attribute Name​

Tag​

Type​

Attribute Description​

Modality​

(0008,0060)​

1​

Type of equipment that originally acquired the data used to create the​

 

 

 

images in this Series. See Section C.7.3.1.1.1 for Defined Terms.​

Series Instance UID​

(0020,000E)​

1​

Unique identifier of the Series.​

Series Number​

(0020,0011)​

2​

A number that identifies this Series.​

Laterality​

(0020,0060)​

2C​

Laterality of (paired) body part examined. Required if the body part​

 

 

 

examined is a paired structure and Image Laterality (0020,0062) or​

 

 

 

Frame Laterality (0020,9072) or Measurement Laterality (0024,0113)​

 

 

 

are not present.​

 

 

 

Enumerated Values:​

 

 

 

R​right​

 

 

 

L​left​

 

 

 

Note​

 

 

 

1.​Some IODs support Image Laterality (0020,0062) at the​

 

 

 

ImagelevelorFrameLaterality(0020,9072)attheFrame​

 

 

 

level in the Frame Anatomy Functional Group Macro or​

 

 

 

MeasurementLaterality(0024,0113)attheMeasurement​

 

 

 

level, which can provide a more comprehensive​

 

 

 

mechanismforspecifyingthelateralityofthebodypart(s)​

 

 

 

being examined.​

 

 

 

2.​There is no value for both left and right, for which Image​

 

 

 

Laterality (0020,0062) at the Image level or Frame​

 

 

 

Laterality (0020,9072) may be used instead.​

 

 

 

3.​Thereisnovalueformedian,forwhichPrimaryAnatomic​

 

 

 

Structure Modifier Sequence (0008,2230) or Anatomic​

 

 

 

Region Modifier Sequence (0008,2220) may be used​

 

 

 

instead.​

Series Date​

(0008,0021)​

3​

Date the Series started.​

Series Time​

(0008,0031)​

3​

Time the Series started.​

Performing Physician's​

(0008,1050)​

3​

Name of the physician(s) administering the Series.​

Name​

 

 

 

- Standard -​

Смотрите также:

«ДОХОДЫ, РАСХОДЫ И ПРИБЫЛЬ КОММЕРЧЕСКОГО БАНКА.»
«ДОХОДЫ, РАСХОДЫ И ПРИБЫЛЬ КОММЕРЧЕСКОГО БАНКА.»
Значение, сущность и содержание социально — педагогической деятельности в организации для детей-сирот и детей, оставшихся без попечения родителей
__RGR2
__RGR2
_11_А. Франс для эл версии
_индив анализ данных
- Интерфейс 485 и оптопорт 11
:Конвергентный подход к проектированию дополнительных общеобразовательных общеразвивающих программ